We are Sorry, This Page doesn't Exist
Spherix to acquire USPTO-aproved pancreatic cancer treatment from CBM BioPharma
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hemispherx announces update on Ampligen pancreatic cancer program
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hemispherx Biopharma Announces IRB Approval Of Clinical Study in Metastatic Triple Negative Breast Cancer In Collaboration With Roswell Park Comprehensive Cancer Center
Hemispherx Biopharma, Inc. read more.....»»
Oncolytics"s combination therapy in pancreatic cancer shows proof-of-concept
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sutro Biopharma ovarian cancer data "impressive," says Piper Sandler
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mereo BioPharma, Cancer Focus announce partnership for Phase 1b/2 of etigilimab
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Scopus BioPharma submits IND to FDA for lead cancer drug candidate
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
XBiotech receives FDA permission to commence trials for pancreatic cancer drug
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Can-Fite BioPharma says cannabis compound inhibits liver cancer grow in study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Surface Oncology treatment of pancreatic cancer granted FDA orphan status
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
GT Biopharma adds second site in Phase 1/2 trial of cancer candidate GTB-3550
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Anixa Biosciences awarded European patent for CAR-T cancer therapy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Can-Fite BioPharma announces data from the Phase II advanced liver cancer study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Marriott CEO Arne Sorenson dies of pancreatic cancer at age 62
Marriott Chief Executive Arne Sorenson, who grew the company into the world’s largest hotel chain and steered it through a global pandemic that has been catastrophic in the travel industry in the pa.....»»
Marriott CEO Arne M. Sorenson dies at 62
The hotel chain leader had been battling pancreatic cancer since 2019......»»
Seagen"s Tukysa approved by European Commission for breast cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AIM ImmunoTech expands pancreatic cancer program to Netherlands patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cue Biopharma initiates dosing in Phase 1 study of cancer candidate CUE-101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vor Biopharma prices upsized IPO at the top of the expected range, raises $177 million
Vor Biopharma Inc. , the Massachusetts-based cell therapy company focused on cancer treatments, said Friday that its upsized initial public offering priced at the top of the expected ran.....»»
Marriott President and CEO Arne Sorenson to reduce schedule for pancreatic cancer treatment
Marriott International Inc. said Tuesday that President and Chief Executive Arne Sorenson will temporarily scale back his schedule to allow him to have more demanding treatment for pa.....»»